Preparation and application of 3, 3-diaminodiphenyl sulfone zinc complex
The preparation and application of 3,3-diaminodiphenylsulfone copper complexes were prepared by reflux and stirring 3,3-diaminodiphenylsulfone and ZnCl2 in anhydrous ethanol for 24 hours at 100°C. The problem of nitrogen metal organic complexes has achieved significant effects on catalytic and anti-cancer activities.
Patent Information
- Application Number
- CN202410932757.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-05
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
A simple and effective method for preparing and applying nitrogen-containing metal organic complexes, especially 3,3-diaminodiphenylsulfone zinc complexes, for catalytic and anti-cancer studies, is lacking in the prior art.
The synthesis process was simplified and achieved by refluxing and stirring 3,3-diaminodiphenylsulfone and ZnCl2 in anhydrous ethanol for 24 hours at 100°C. One-step preparation.
It has achieved efficient preparation of 3,3-diaminodiphenylsulfone copper complex, with simple process and convenient operation, and demonstrated its significant effect in catalytic and anti-cancer activities, especially in inhibiting lung cancer, liver cancer, colon cancer and breast cancer Inhibitory activity on cancer cells.
Smart Images

Figure CN118894873A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a metal organic coordination compound (complex) and its application, in particular to a nitrogen-containing metal organic complex and its application, more specifically to the preparation and application of a 3,3-diaminodiphenyl sulfone zinc complex. Background Art
[0002] With the development of organic chemistry, metal organic compounds are increasingly used in organic synthesis, and are one of the most active fields in organic chemistry. They have been widely used in organic synthesis reactions. The emergence of asymmetric synthesis reactions catalyzed by chiral ligands and transition metal complexes in the late 1960s greatly accelerated the research on chiral drugs.
[0003] References:
[0004] 1. Zhang, Xiao;
[0005] 2. Vimala, TM; Swaminathan, S. Crystal structure of copper ethyl sulfatetetrahydrate, Current Science (1969), 38(15), 362. Summary of the invention
[0006] The present invention aims to provide a Zn-N metal organic complex for application in the field of catalysis, and the technical problem to be solved is to select 3,3-diaminodiphenyl sulfone as a ligand to synthesize 3,3-diaminodiphenyl sulfone copper complex in one step.
[0007] The 3,3-diaminodiphenyl sulfone copper complex referred to in the present invention is a complex shown in the following chemical formula prepared by reflux stirring of 3,3-diaminodiphenyl sulfone and ZnCl2 at 100° C. for 24 hours in an ethanol solvent:
[0008]
[0009] Chemical name: 3,3-diaminodiphenyl sulfone zinc chloride complex, referred to as complex (I).
[0010] The synthesis method includes synthesis and separation. The synthesis is to weigh 3,3-diaminodiphenyl sulfone (0.2482g, 1mmol), ZnCl2 (0.2726g, 2mmol) and dissolve in 50ml of anhydrous ethanol, reflux and stir for 24 hours, and then filter hot. The filtrate is placed at room temperature for natural volatilization. After a period of time, light brown crystals are precipitated. The synthesis reaction is as follows:
[0011]
[0012] The synthetic method can obtain the target product in one step, and the process is simple and the operation is convenient.
[0013] The reaction mechanism of the reaction is that after 3,3-diaminodiphenyl sulfone and ZnCl2 are refluxed and stirred in anhydrous ethanol for 24 hours, zinc chloride coordinates with the amino group in 3,3-diaminodiphenyl sulfone to form a zinc complex in one step. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 This is an X-ray diffraction analysis diagram of 3,3-diaminodiphenyl sulfone copper complex. DETAILED DESCRIPTION
[0015] Weigh 3,3-diaminodiphenyl sulfone (0.2482 g, 1 mmol) and ZnCl2 (0.2726 g, 2 mmol) and dissolve them in 50 ml of anhydrous ethanol. After stirring under reflux at 100°C for 24 hours, filter while hot and allow the filtrate to evaporate naturally at room temperature. After a period of time, light brown crystals precipitate with a melting point of mp: 270°C. Yield: 77.9%. Its molecular formula is: [C 24 H 24 Cl2 N4 O4 S2Zn], elemental analysis (measured value, %): C, 45.75%; H, 4.066; N, 8.97; calculated value (%): C, 45.51; H: 3.792; N: 8.85; ESI-MS, m / z: 631.89 [MH] + IR main characteristic peaks (KBr, cm -1 ): 3580,3395,3130,3065,3010,1605,1480,1300,1150,855,790,712,615,520.
[0016] The crystal data of the complex are as follows:
[0017]
[0018]
[0019] Typical bond length data for crystals:
[0020]
[0021]
[0022] Typical bond angle data of crystals:
[0023]
[0024]
[0025] Symmetry transformations used to generate equivalent atoms: #1-x+3 / 2,y,-z+1 / 2.
[0027] 3. Anticancer activity of zinc complex (I)
[0028] The zinc complex I synthesized by the present invention based on the structure of the active natural product shows certain inhibitory activity in tests of cancer cells such as lung cancer A-549 and liver cancer SMMC-7721, colon cancer SW480 and breast cancer MDA-MB-231. The results of the anticancer activity test inhibition rate are shown in Table 1:
[0029] Table 1. Anticancer activity data of zinc complexes (I)
[0030]
Claims
1. A zinc complex represented by the following chemical formula (I):
2. The zinc complex (I) crystal according to claim 1, wherein the unit cell parameters are as follows: at 273 K, on an Oxford X-ray single crystal diffractometer, using MoKα rays monochromatized by a graphite monochromator, Diffraction data are collected in an ω-θ scanning mode, characterized in that The crystal belongs to the monoclinic system, P21 / c; a=90°; b=98.700(2); g=90°.
3. The method for synthesizing the zinc complex (I) according to claim 1, comprising synthesis, separation and purification. The synthesis is as follows: 3,3-diaminodiphenyl sulfone (0.2482 g, 1 mmol) and ZnCl2 (0.2726 g, 2 mmol) are weighed and dissolved in 50 ml of anhydrous ethanol. After reflux stirring for 24 hours, hot filtration is performed, and the filtrate is left to evaporate naturally at room temperature. After a period of time, light brown crystals are precipitated.
4. The use of the zinc complex (I) according to claim 1, characterized in that: It can be used as an anticancer agent and shows certain inhibitory activity in experiments on lung cancer A-549, liver cancer SMMC-7721, colon cancer SW480 and breast cancer MDA-MB-231, with inhibition rates of 15.88±1.07; 3.52±0.09; 19.89±1.2 and 18.68±1.89, respectively.
Citation Information
Patent Citations
Preparation and application of zinc complex
CN117964644A
